Ed Susman

Articles

ASCO PROSTATE: Potency Drugs Improve Sexual Function After Prostate Cancer Therapy

February 26, 2007

KISSIMMEE, Fla. -- Prostate cancer patients taking sildenafil (Viagra) or its ilk reported improved sexual functioning and interest following radiation therapy and radical prostatectomy, researchers here reported.

ASCO PROSTATE: Exercise Improves Prostate Cancer Patients' Quality of Life

February 23, 2007

KISSIMMEE, Fla. -- Aerobic or resistance exercise improved quality-of-life measures among men undergoing radiation treatment for prostate cancer, researchers here reported.

ASCO PROSTATE: Radiation for Rectal Cancer May Protect Prostate

February 22, 2007

KISSIMMEE, Fla. - Men who undergo external-beam radiation treatment for rectal cancer appear to have a long-term reduced risk of prostate cancer.

ASCO PROSTATE: Prostate Cancer Prevention Role Seen for BPH Drug

February 22, 2007

KISSIMMEE, Fla. -- Dutasteride (Avodart), a drug used to treat benign prostatic hyperplasia, may also prevent the development of prostate cancer by inducing genetic changes at the cellular level, researchers reported today.

ASCO GI: Tracking Molecular Targets Essential to of GIST Therapy

January 30, 2007

ORLANDO -- In gastrointestinal stromal tumors (GIST), the central -- and potentially initiating -- oncogenic mechanisms can be identified in virtually all cases, a pathologist said here.

ASCO GI: Eloxatin Seen Safe as Add-On to Neoadjuvant Chemoradiation for Rectal Cancer

January 29, 2007

ORLANDO -- Adding Eloxatin (oxaliplatin) to the neoadjuvant chemotherapy mix for rectal cancer did not affect radiation dosing nor limit the ability to perform surgery, researchers here reported.

ASCO GI: EGFR Inhibitors Demonstrate Efficacy in Gastrointestinal Malignancies

January 29, 2007

ORLANDO -- Epidermal growth factor receptor inhibitors (EGFR) vary in their efficacy in gastrointestinal cancers, researchers here reported.

ASCO GI: Adjuvant Chemotherapy Plus Chemoradiation May Improve Pancreatic Cancer Survival

January 29, 2007

ORLANDO -- Gemzar (gemcitabine) plus Eloxatin (oxaliplatin) adjuvant chemotherapy, followed by chemoradiation ,can improve one-year post-resection recurrence-free survival in pancreatic cancer, suggests a small French study.

ASCO GI: Understanding Tumor Biology Key to Treatment of Gastrointestinal Cancers

January 25, 2007

ORLANDO -- Treatment of gastrointestinal cancers can be improved with a more thorough understanding of tumor biology, researchers here reported.

ASCO GI: Small Benefit Seen for Erbitux Plus Camptosar in Refractory Gastric Cancer

January 23, 2007

ORLANDO -- Treatment-refractory advanced gastric cancers may respond to combination therapy with Erbitux (cetuximab) and Camptosar (irinotecan), researchers reported here.